Bellerophon Therapeutics, Inc.
BLPH
BLPH was delisted on the 13th of October, 2023.
19 hedge funds and large institutions have $28.7M invested in Bellerophon Therapeutics, Inc. in 2020 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 5 closing their positions.
140% more capital invested
Capital invested by funds: $12M → $28.7M (+$16.7M)
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
67% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 3
60% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 5
0% more funds holding
Funds holding: 19 → 19 (0)
15.68% less ownership
Funds ownership: 41.31% → 25.63% (-16%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BC
Boxer Capital
San Diego,
California
|
+$662K |
| 2 |
PI
Pennant Investors
Summit,
New Jersey
|
+$470K |
| 3 |
Renaissance Technologies
New York
|
+$250K |
| 4 |
TI
Telemetry Investments
New York
|
+$184K |
| 5 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
+$160K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NMVA
New Mountain Vantage Advisers
New York
|
-$6.09M |
| 2 |
Bank of New York Mellon
New York
|
-$60K |
| 3 |
LPL Financial
San Diego,
California
|
-$48K |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$27K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
-$14.4K |
BLPH Hedge Fund Activity: Q1 2020 in Review
19 of the 4,548 institutional investors tracked by Wall St. Rank reported a position in Bellerophon Therapeutics, Inc. (BLPH) for Q1 2020, worth a combined $28.7M — up 140% from $12M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new BLPH positions and 5 closed out — a net gain of 3 holders — while 5 added to existing stakes and 3 trimmed.
The largest buyer was Boxer Capital, opening a new position worth an estimated $662K. The largest seller was New Mountain Vantage Advisers, cutting an estimated $6.09M.
- 19 institutional investors held Bellerophon Therapeutics, Inc. (BLPH) as of Q1 2020, unchanged from Q4 2019.
- Funds reported $28.7M of Bellerophon Therapeutics, Inc. stock for Q1 2020, up 140% quarter-over-quarter.
- 8 funds opened new Bellerophon Therapeutics, Inc. positions in Q1 2020 and 5 closed out, a net change of +3 holders.
- The largest Bellerophon Therapeutics, Inc. buyer in Q1 2020 was Boxer Capital, an estimated $662K added.
- The largest Bellerophon Therapeutics, Inc. seller in Q1 2020 was New Mountain Vantage Advisers, an estimated $6.09M sold.
Based on aggregated 13F filings for Q1 2020.